User profiles for Craig T. Jordan

Craig T Jordan

Professor or Medicine, University of Colorado
Verified email at cuanschutz.edu
Cited by 29198

[PDF][PDF] BCL-2 inhibition targets oxidative phosphorylation and selectively eradicates quiescent human leukemia stem cells

…, JL Liesveld, PS Brookes, MW Becker, CT Jordan - Cell stem cell, 2013 - cell.com
Most forms of chemotherapy employ mechanisms involving induction of oxidative stress, a
strategy that can be effective due to the elevated oxidative state commonly observed in cancer …

Functional genomic landscape of acute myeloid leukaemia

…, MW Deininger, L Drusbosky, CS Hourigan, CT Jordan… - Nature, 2018 - nature.com
The implementation of targeted therapies for acute myeloid leukaemia (AML) has been
challenging because of the complex mutational patterns within and across patients as well as a …

The increasing complexity of the cancer stem cell paradigm

JM Rosen, CT Jordan - science, 2009 - science.org
The investigation and study of cancer stem cells (CSCs) have received enormous attention
over the past 5 to 10 years but remain topics of considerable controversy. Opinions about the …

Cancer stem cells

CT Jordan, ML Guzman, M Noble - New England Journal of …, 2006 - Mass Medical Soc
Cancer Stem Cells | NEJM Skip to main content NEJM Group Follow Us Facebook Twitter
Instagram YouTube LinkedIn Prepare to become a physician, build your knowledge, lead a …

Nuclear factor-κB is constitutively activated in primitive human acute myelogenous leukemia cells

…, DA Rizzieri, SM Luger, CT Jordan - Blood, The Journal …, 2001 - ashpublications.org
Human acute myelogenous leukemia (AML) is thought to arise from a rare population of
malignant stem cells. Cells of this nature, herein referred to as leukemic stem cells (LSCs), have …

The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells

…, X Li, DR Peterson, DS Howard, CT Jordan - Blood, 2005 - ashpublications.org
Recent studies have described malignant stem cells as central to the initiation, growth, and
potential relapse of acute and chronic myelogenous leukemia (AML and CML). Because of …

A receptor tyrosine kinase specific to hematopoietic stem and progenitor cell-enriched populations

W Matthews, CT Jordan, GW Wiegand, D Pardoll… - Cell, 1991 - cell.com
To elucidate the molecular biology of the hematopoietic stem cell, we have begun to isolate
genes from murine cell populations enriched in stem cell activity. One such cDNA encodes a …

Clonal and systemic analysis of long-term hematopoiesis in the mouse.

CT Jordan, IR Lemischka - Genes & development, 1990 - genesdev.cshlp.org
We have analyzed the temporal in vivo fate of 142 individual stem cell clones in 63
reconstituted mice. Long-term sequential analyses of the four major peripheral blood lineages, …

A receptor tyrosine kinase cDNA isolated from a population of enriched primitive hematopoietic cells and exhibiting close genetic linkage to c-kit.

W Matthews, CT Jordan, M Gavin… - Proceedings of the …, 1991 - National Acad Sciences
We have cloned a receptor tyrosine kinase cDNA, designated fetal liver kinase 1 (Flk-1), from
mouse cell populations enriched for hematopoietic stem and progenitor cells. Sequence …

Preferential induction of apoptosis for primary human leukemic stem cells

…, RM Rossi, SJ Szilvassy, CT Jordan - Proceedings of the …, 2002 - National Acad Sciences
Acute myelogenous leukemia (AML) is typically a disease of stem/progenitor cell origin.
Interestingly, the leukemic stem cell (LSC) shares many characteristics with normal …